Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis (original) (raw)
Noseworthy J, Lucchinetti C, Rodriguez M, et al.: Multiple sclerosis. N Engl J Med 2000, **343:**938–952. ArticlePubMedCAS Google Scholar
Schmidt S: Candidate autoantigens in multiple sclerosis. Mult Scler 1999, **5:**147–160. PubMedCAS Google Scholar
Huitinga I, van Rooijen N, de Groot CJ, et al.: Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990, **172:**1025–1033. ArticlePubMedCAS Google Scholar
De Jager PL, Hafler DA: New therapeutic approaches for multiple sclerosis. Annu Rev Med 2007, **58:**417–432. ArticlePubMed Google Scholar
Kuhlmann T, Lingfeld G, Bitsch A, et al.: Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002, **125:**2202–2212. ArticlePubMed Google Scholar
Herrero-Herranz E, Pardo LA, Gold R, Linker RA: Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 2008, **30:**162–173. ArticlePubMedCAS Google Scholar
Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al.: Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, **128:**2705–2712. ArticlePubMed Google Scholar
Ingle GT, Stevenson VL, Miller DH, et al.: Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 2003, **126:**2528–2536. ArticlePubMedCAS Google Scholar
Trapp BD, Peterson J, Ransohoff RM, et al.: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, **338:**278–285. ArticlePubMedCAS Google Scholar
Lovas G, Szilágyi N, Majtényi K, et al.: Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000, **123:**308–317. ArticlePubMed Google Scholar
Lu ZH, Chakraborty G, Ledeen RW, et al.: N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain. Brain Res Mol Brain Res 2004, **122:**71–78. ArticlePubMedCAS Google Scholar
Signoretti S, Marmarou A, Tavazzi B, et al.: N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following traumatic brain injury. J Neurotrauma 2001, **18:**977–991. ArticlePubMedCAS Google Scholar
Benarroch EE: N-Acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology 2008, **70:**1353–1357. ArticlePubMed Google Scholar
Fu L, Matthews PM, De Stefano N, et al.: Imaging axonal damage of normal appearing white matter in multiple sclerosis. Brain 1998, **121:**103–113. ArticlePubMed Google Scholar
Khan O, Shen Y, Caon C, et al.: Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis. Mult Scler 2005, **11:**646–651. ArticlePubMedCAS Google Scholar
Bjartmar C, Kidd G, Mork S, et al.: Neurological disability correlates with spinal cord axonal loss and reduced Nacetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000, **48:**893–901. ArticlePubMedCAS Google Scholar
Lu F, Selak M, O’Conner J, et al.: Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000, **177:**95–103. ArticlePubMedCAS Google Scholar
Dutta R, McDonough J, Yin X, et al.: Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006, **59:**478–489. ArticlePubMedCAS Google Scholar
Bernardi P, Krauskopf A, Basso E, et al.: The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 2006, **273:**2077–2099. ArticlePubMedCAS Google Scholar
Brown GC, Borutaite V: Nitric oxide, mitochondria, and cell death. IUBMB Life 2001, **52:**189–195. ArticlePubMedCAS Google Scholar
Cleeter MW, Cooper JM, Darley-Usmar VM, et al.: Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994, **345:**50–54. ArticlePubMedCAS Google Scholar
Brown GC, Borutaite V: Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic Biol Med 2002, **33:**1440–1450. ArticlePubMedCAS Google Scholar
Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, **271:**C1424–C1437. PubMedCAS Google Scholar
Pacher P, Beckman JS, Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, **87:**315–424. ArticlePubMedCAS Google Scholar
Cross A, Manning PT, Keeling RM, et al.: Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 1998, **88:**45–56. ArticlePubMedCAS Google Scholar
Groom AJ, Smith T, Turski L: Multiple sclerosis and glutamate. Ann N Y Acad Sci 2003, **993:**229–275. ArticlePubMedCAS Google Scholar
Gunter TE, Yule DL, Gunter KK, et al.: Calcium and mitochondria. FEBS Lett 2004, **567:**96–102. ArticlePubMedCAS Google Scholar
Srinivasan R, Sailasuta N, Hurd R, et al.: Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005, **128:**1016–1025. ArticlePubMed Google Scholar
Craner M, Newcombe J, Black JA, et al.: Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci U S A 2004, **101:**8168–8173. ArticlePubMedCAS Google Scholar
Stys PK, Waxman SG, Ransom BR: Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na+-Ca2+ exchanger. J Neurosci 1992, **12:**430–439. PubMedCAS Google Scholar
Krieger C, Duchen MR: Mitochondria, Ca2+ and neurodegenerative disease. Eur J Pharmacol 2002, **447:**177–188. ArticlePubMedCAS Google Scholar
Gunter TE, Sheu SS: Characteristics and possible functions of mitochondrial Ca(2+) transport mechanisms. Biochim Biophys Acta 2009 Jan 6 (Epub ahead of print).
Griffiths EJ, Halestrap AP: Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 1993, **25:**1461–1469. ArticlePubMedCAS Google Scholar
Friberg H, Ferrand-Drake M, Bengtsson F, et al.: Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 1998, **18:**5151–5159. PubMedCAS Google Scholar
Basso E, Fante L, Folkes J, et al.: Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J Biol Chem 2005, **280:**18558–18561. ArticlePubMedCAS Google Scholar
Baines CP, Kaiser RA, Purcell NH, et al.: Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, **434:**658–662. ArticlePubMedCAS Google Scholar
Schinzel AC, Takeuchi O, Huang Z, et al.: Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A 2007, **102:**12005–12010. Article Google Scholar
Forte M, Gold BG, Marracci G, et al.: Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci U S A 2007, **104:**7558–7563. ArticlePubMedCAS Google Scholar
Chen H, Chan DC: Critical dependence of neurons on mitochondrial dynamics. Curr Opin Cell Biol 2006, **18:**453–459. ArticlePubMedCAS Google Scholar
Hollenbeck PJ, Saxton WM: The axonal transport of mitochondria. J Cell Sci 2005, **118:**5411–5419. ArticlePubMedCAS Google Scholar
Saotome M, Safiulina D, Szabadkai G, et al.: Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci U S A 2008, **52:**20728–20733. Article Google Scholar
Wang X, Schwarz TL: The mechanism of Ca2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell 2009, **136:**163–174. ArticlePubMedCAS Google Scholar
Macaskill AF, Rinholm JE, Twelvetrees AE, et al.: Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 2009, **61:**541–555. ArticlePubMedCAS Google Scholar
Rintoul GL, Bennett VJ, Papaconstandinou NA, et al.: Nitric oxide inhibits mitochondrial movement in forebrain neurons associated with disruption of mitochondrial membrane potential. J Neurochem 2006, **97:**800–806. ArticlePubMedCAS Google Scholar
Stagi M, Gorlovoy P, Larionov S, et al.: Unloading kinesin transported cargoes from the tubulin track via the inflammatory c-Jun N-terminal kinase pathway. FASEB J 2006, **20:**2573–2575. ArticlePubMedCAS Google Scholar
Morfini GA, You YM, Pollema SL, et al.: Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci 2009, **12:**864–871. ArticlePubMedCAS Google Scholar
Nikolaev A, McLaughlin T, O’Leary DD, et al.: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, **457:**981–989. ArticlePubMedCAS Google Scholar
Witt A, Brady ST: Unwrapping new layers of complexity in axon/glial relationships. Glia 2000, **29:**112–117. ArticlePubMedCAS Google Scholar
Misgeld T, Kerschensteiner M, Bareyre FM, et al.: Imaging axonal transport of mitochondria in vivo. Nat Methods 2007, **4:**559–561. ArticlePubMedCAS Google Scholar